BPC-157 is a naturally occurring peptide fragment with striking healing and anti-inflammatory effects in animal models. Here is what the evidence says, what oral capsules can realistically deliver, and how to source a quality product.
BPC-157 — body protection compound 157 — is a 15-amino acid peptide fragment derived from a protein found in human gastric juice. It has generated significant interest in longevity and sports medicine communities over the past decade, primarily due to animal research showing dramatic healing effects across multiple tissue types: gut, tendons, ligaments, muscle, bone, and nervous tissue. It also appears to modulate the nitric oxide system, growth hormone receptor signaling, and inflammatory pathways.
The honest caveat is that human clinical trial data for BPC-157 remains limited — most of the compelling evidence is from rodent models. But the animal data is unusually robust for a single compound: dozens of independent studies across multiple research groups, consistent positive findings, and good safety profiles. This is what has driven its adoption among longevity physicians like Peter Attia and Andrew Huberman, who have publicly discussed it.
Here is a clear-eyed summary of what is known, what oral capsules can realistically deliver, and how to find a quality product.
Gut healing: BPC-157 was originally studied for gastrointestinal protection. Multiple studies show it accelerates healing of gastric ulcers, colitis, and intestinal fistulas in rodent models — faster than any approved drug treatment in comparative studies. It appears to work by upregulating growth hormone receptor expression in gut tissue and stimulating angiogenesis (new blood vessel formation) in the intestinal wall.
Tendon and ligament repair: A series of Croatian studies (Sikiric et al.) found that BPC-157 dramatically accelerated tendon and ligament healing in rats — superior to corticosteroid treatment without the attendant tissue weakening. Athletes with chronic tendinopathy represent a significant portion of the current interest in BPC-157.
Muscle healing: Studies in rats with crushed or transected muscles showed significantly faster recovery with BPC-157 treatment, with one study demonstrating near-complete functional recovery versus partial recovery in controls.
Brain and nervous system: BPC-157 has shown neuroprotective effects in traumatic brain injury models and has modulated dopaminergic pathways in ways that suggest potential for mood and addiction applications.
Anti-inflammatory: Across tissue types, BPC-157 consistently reduces pro-inflammatory markers (TNF-α, IL-1β) and upregulates anti-inflammatory pathways.
BPC-157 can be taken orally or via subcutaneous injection. The injectable route delivers the peptide directly into circulation; oral administration requires the peptide to survive gastric acid and intestinal digestion, which is a legitimate concern.
However, BPC-157 is notable among peptides for its relative stability in gastric acid — the name "body protection compound" refers in part to its resistance to degradation in the GI environment. The original gut healing research used oral gavage (oral dosing) in rodents with comparable efficacy to injection in GI-specific outcomes. For systemic effects (tendons, nervous system), oral bioavailability is less established, but some researchers argue that enough intact peptide or active metabolites reach systemic circulation to produce effects.
The practical reality: oral capsules are accessible without a prescription and represent the most viable option for most people.
The key challenge with BPC-157 supplements is quality verification. Because BPC-157 is not an FDA-regulated drug, product quality varies enormously. What to look for:
Typical oral dosing in the self-experimentation community is 250–500 mcg/day, taken in the morning on an empty stomach. For gut healing specifically, some practitioners cycle it over 4–6 weeks. For musculoskeletal issues, longer protocols of 8–12 weeks are more common.
BPC-157 is among the most intriguing peptides in the longevity and sports medicine space. The animal data is compelling, the safety profile is excellent, and growing anecdotal evidence from practitioners suggests real-world effects that align with the mechanism. Human trial data is the missing piece — but the existing evidence base is strong enough that many serious longevity practitioners consider it a reasonable addition to a comprehensive protocol, particularly for gut health and injury recovery.